Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy.
Authors: Fabbri L, Lagadec L, Guérin E, Lecourt H, Baille D, Besse L, Messaoudi C, Désaubry L, Abou-Hamdan H, Roy S, Lombard B, Loew D, Scoazec JY, Robert C, Vagner S
Journal: EMBO molecular medicine
group therapy
mental health
open access